Researchers at [b]Mayo Clinic[/b] have demonstrated in a mouse model that their recently developed synthetic peptide carrier is a potential delivery vehicle for brain cancer chemotherapy drugs and other neurological medications, reports [s]Science Daily[/s]. Dr Robert Jenkins, senior author of the study, says the method meets three of five requirements for a usable therapy. ‘It’s feasible as a repeated procedure; it should be relatively easy to introduce into medical practice; and it would work for any size or location of brain tumour.
[link url=http://www.sciencedaily.com/releases/2014/06/140604105317.htm]Full Science Daily report[/link]
[link url=http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0097655]PLOS One abstract[/link]